Official Title
Multicentric Sensitivity Assessment of Antibody Diagnostic Tests Developed for Diagnosis of SARS-CoV2 Infection
Brief Summary

The primary objective of this study is to test the diagnostic sensitivity of antibody tests for the diagnosis of SARS-CoV2 infection, available to clinical laboratories, within a national network of hospitals carrying out research activities. Test the diagnostic specificity of antibody tests for the diagnosis of SARS-CoV2 infection. Complete a systematic evaluation of the different approaches. Perform Health technology Assessment (HITA) of the methodologies under study, in order to verify their reliability to the immunoglobulin levels produced by each individual exposed patient.

Status
Unknown status
Conditions
COVID19
Eligibility Criteria

Inclusion Criteria:

All patients or individuals exposed to Sars-Cov2 Infection.

Exclusion Criteria:

There are no criteria for excluding patients or individuals, if not the refusal to
participate to project

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
Italy
Locations

Istituto Ortopedico Galeazzi
Milan, Italy

Investigators

Giuseppe Banfi, Principal Investigator
IRCCS Orthopedic Institute Galeazzi

Sponsors / Collaborators
Istituto Ortopedico Galeazzi
NCT Number
NCT04678024
Keywords
test sierologici
MeSH Terms
COVID-19